BackDermapharm Holding SE Overview

Dermapharm Holding SE Receivables

Latest receivables for DMPHF: $140M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$138.79M
↑ 18.06% YoYΔ $21.23M vs prior year quarter

Peer trimmed avg / median

Loading

Dermapharm Holding SE Receivables History

Loading

Dermapharm Holding SE vs. peers: Receivables Comparison

Loading

Dermapharm Holding SE Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Dermapharm Holding SE (DMPHF) FAQ

As of the most recent data (June 2026), DMPHF shows a receivables of $140M. That compares with $120M in the prior-year period — up 18.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMPHF's receivables is now $140M (was $120M) — a 18.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dermapharm Holding SE is outperforming or lagging.

Tracking DMPHF's receivables over time shows whether Dermapharm Holding SE is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $120M in the prior-year period — up 18.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Dermapharm Holding SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $140M) with ownership activity and broader fundamentals.